Institutional members access full text with Ovid®

Share this article on:

Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett’s Esophagus

Thota, Prashanthi N. MD; Zackria, Shamiq MD; Sanaka, Madhusudhan R. MD; Patil, Deepa MD; Goldblum, John MD; Lopez, Rocio MS; Chak, Amitabh MD

Journal of Clinical Gastroenterology: May/June 2017 - Volume 51 - Issue 5 - p 402–406
doi: 10.1097/MCG.0000000000000559
ALIMENTARY TRACT: Original Articles

Goals: Our aim was to study the prevalence of dysplasia and progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in African Americans (AA) with Barrett’s esophagus (BE) and compare it with that of non-Hispanic white (NHW) controls.

Background: BE, a precursor of EAC, is a disease of predominantly white men and is uncommon in AA. The prevalence of dysplasia and progression to HGD and EAC in AA patients with BE is not clearly known.

Study: All AA or NHW patients with confirmed BE, that is specialized intestinal metaplasia, seen between 2002 and 2013 at our institution were included. Variables such as age, gender, medication use, the body mass index, the date of endoscopy, the hiatal hernia size, the BE length, and histologic findings were noted. Progression to HGD/EAC was evaluated.

Results: Fifty-two AA and 2394 NHW patients with BE were identified. There was a higher percentage of women in the AA cohort (46.2%) than in the NHW cohort (24.9%, P<0.001). Nondysplastic BE was more prevalent in AA than in NHW (80.8% vs. 68.4%, P=0.058). In the surveillance cohort of 20 AA and 991 NHW, no racial differences in progression to HGD/EAC were observed during a median follow-up of 43 months.

Conclusions: This study includes the largest number of AA with histologically confirmed BE reported so far. About 46.2% of the AA cohort with BE in our study consisted of women. There was a trend toward a higher prevalence of nondysplastic BE in AA compared with NHW.

Departments of *Gastroenterology and Hepatology


Biostatistics, Cleveland Clinic

§Department of Gastroenterology, University Hospitals, Cleveland, OH

The authors declare that they have nothing to disclose.

Address correspondence to: Prashanthi N. Thota, MD, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH 44195 (e-mail:

Received February 4, 2016

Accepted May 2, 2016

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.